{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:10:51Z","timestamp":1772565051118,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PO1 HL76611"],"award-info":[{"award-number":["PO1 HL76611"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 AG034676"],"award-info":[{"award-number":["RO1 AG034676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 HL55502"],"award-info":[{"award-number":["RO1 HL55502"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 HL136340"],"award-info":[{"award-number":["RO1 HL136340"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16SDG29930003"],"award-info":[{"award-number":["16SDG29930003"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.mayocp.2018.05.027","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T07:38:50Z","timestamp":1533109130000},"page":"980-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5168-8381","authenticated-orcid":false,"given":"Valentina","family":"Cannone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Buglioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Jeson","family":"Sangaralingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-0647","authenticated-orcid":false,"given":"Christopher","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent R.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Rodeheffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret M.","family":"Redfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Sarzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John C.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mayocp.2018.05.027_bib1","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J\u00a0Lab Clin Med"},{"issue":"24","key":"10.1016\/j.mayocp.2018.05.027_bib2","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/CIRCULATIONAHA.106.668715","article-title":"Aldosterone and cardiovascular disease: smoke and fire","volume":"114","author":"Calhoun","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mayocp.2018.05.027_bib3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1161\/HYPERTENSIONAHA.116.07806","article-title":"Body mass index predicts 24-hour urinary aldosterone levels in patients with resistant hypertension","volume":"68","author":"Dudenbostel","year":"2016","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.mayocp.2018.05.027_bib4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/HYPERTENSIONAHA.109.141531","article-title":"Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study","volume":"55","author":"Gaddam","year":"2010","journal-title":"Hypertension"},{"issue":"10008","key":"10.1016\/j.mayocp.2018.05.027_bib5","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomized, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2018.05.027_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/HYPERTENSIONAHA.114.03936","article-title":"Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease","volume":"65","author":"Buglioni","year":"2015","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.mayocp.2018.05.027_bib7","first-page":"e00250514","article-title":"Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: a 4-year follow-up","volume":"4","author":"Buglioni","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.mayocp.2018.05.027_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.mayocp.2018.05.027_bib9","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.mayocp.2018.05.027_bib10","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2018.05.027_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2015.10.037","article-title":"Generalizability of SPRINT results to the US adult population","volume":"67","author":"Bress","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.mayocp.2018.05.027_bib12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"16","key":"10.1016\/j.mayocp.2018.05.027_bib13","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jacc.2012.05.049","article-title":"Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP","volume":"60","author":"Macheret","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2018.05.027_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/01.CIR.0000112582.16683.EA","article-title":"Impact of obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2018.05.027_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamacardio.2017.4207","article-title":"Racial differences in plasma levels of N-terminal pro-B-type natriuretic peptide and outcomes: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"3","author":"Bajaj","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2018.05.027_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"issue":"4742","key":"10.1016\/j.mayocp.2018.05.027_bib17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.2935937","article-title":"Atrial natriuretic peptide elevation in congestive heart failure in the human","volume":"231","author":"Burnett","year":"1986","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mayocp.2018.05.027_bib18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCHEARTFAILURE.113.000885","article-title":"Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation","volume":"7","author":"Nakagawa","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.mayocp.2018.05.027_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2011.05.011","article-title":"A\u00a0genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community","volume":"58","author":"Cannone","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.05.027_bib20","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.2337\/dc12-2337","article-title":"The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population","volume":"36","author":"Cannone","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.mayocp.2018.05.027_bib21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.mayocp.2018.05.027_bib22","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1152\/ajpregu.00499.2015","article-title":"Insulin\/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway","volume":"311","author":"Bordicchia","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"21","key":"10.1016\/j.mayocp.2018.05.027_bib23","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.2017.18605","article-title":"The New 2017 ACC\/AHA Guidelines \u201cUp the pressure\u201d on diagnosis and treatment of hypertension","volume":"318","author":"Greenland","year":"2017","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.mayocp.2018.05.027_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jchf.2015.02.008","article-title":"Racial differences in natriuretic eptide levels: the Dallas Heart Study","volume":"3","author":"Gupta","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.mayocp.2018.05.027_bib25","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.2337\/dc12-2562","article-title":"Aldosterone, c-reactive protein, and plasma b-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study","volume":"36","author":"Musani","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mayocp.2018.05.027_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jamacardio.2017.4208","article-title":"Natriuretic peptide deficiency: when there is too little of a good thing","volume":"3","author":"Wang","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2018.05.027_bib27","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.amjcard.2017.06.030","article-title":"Differences in natriuretic peptide levels by race\/ethnicity (from the multi-ethnic study of atherosclerosis)","volume":"120","author":"Gupta","year":"2017","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2018.05.027_bib28","doi-asserted-by":"crossref","first-page":"e000478","DOI":"10.1161\/JAHA.113.000478","article-title":"Twenty-two-year population trends in sodium and potassium consumption: the Minnesota Heart Survey","volume":"2","author":"Meyer","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.mayocp.2018.05.027_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/HYPERTENSIONAHA.116.06582","article-title":"Building on a legacy of hypertension research: charting our future together","volume":"69","author":"Mensah","year":"2017","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.mayocp.2018.05.027_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jamacardio.2016.1878","article-title":"Mineralocorticoid receptor antagonists in the management of heart failure and resistant hypertension","volume":"1","author":"Flatt","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"9722","key":"10.1016\/j.mayocp.2018.05.027_bib31","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(09)61966-8","article-title":"Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomized, double-blind, placebo-controlled, active comparator study","volume":"375","author":"Ruilope","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.mayocp.2018.05.027_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacbts.2016.10.001","article-title":"Innovative therapeutics: designer natriuretic peptides","volume":"1","author":"Meems","year":"2016","journal-title":"JACC Basic Transl Sci"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618304105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618304105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:29:38Z","timestamp":1758418178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618304105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0025619618304105"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.05.027","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}